CTRB1

Chymotrypsinogen B · P17538 · CTRB1 on Sugi Atlas →

41,464 patent compounds predicted against CTRB1, 24,824 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL464430 SCHEMBL464430 0.66 7/20
SCHEMBL639626 SCHEMBL639626 0.71 5/20
SCHEMBL40779 SCHEMBL40779 0.58 5/20
SCHEMBL40780 SCHEMBL40780 0.58 5/20
SCHEMBL40781 SCHEMBL40781 0.58 5/20
SCHEMBL334301 SCHEMBL334301 0.57 5/20
SCHEMBL334424 SCHEMBL334424 0.57 5/20
SCHEMBL26065 SCHEMBL26065 0.50 5/20
SCHEMBL464419 SCHEMBL464419 0.48 5/20
SCHEMBL295654 SCHEMBL295654 0.45 5/20
SCHEMBL159552 SCHEMBL159552 0.42 5/20
SCHEMBL159553 SCHEMBL159553 0.42 5/20
SCHEMBL380599 SCHEMBL380599 0.42 5/20
SCHEMBL380600 SCHEMBL380600 0.42 5/20
SCHEMBL476353 SCHEMBL476353 0.42 5/20
SCHEMBL574263 SCHEMBL574263 0.42 5/20
SCHEMBL464463 SCHEMBL464463 0.40 5/20
SCHEMBL121884 SCHEMBL121884 0.38 5/20
SCHEMBL259640 SCHEMBL259640 0.62 4/20
SCHEMBL165896 SCHEMBL165896 0.61 4/20

Clinical trials — most relevant to CTRB1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus PHASE4COMPLETED
Molecular Mechanisms of Type 2 Diabetes Mellitus PHASE4COMPLETED
A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema PHASE3COMPLETED
Efficacy and Safety of GNR-038 vs Berinert® in Patients With Hereditary Angioedema PHASE2/PHASE3WITHDRAWN
A Pilot Study of Use of Calcium Channel Blocker to Decrease Inflammation and Pain in Hereditary Pancreatitis PHASE1/PHASE2COMPLETED
Comparative Clinical Study to Evaluate the Possible Efficacy and Safety of Oral N-Acetyl Cysteine Versus Rectal Diclofenac in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis PHASE1/PHASE2COMPLETED
Genetic Determinism of Epithelial Barrier Defects in Irritable Bowel Syndrome nanWITHDRAWN
Acute Pancreatitis Targets (APT) Study nanCOMPLETED
Choline Nutritional Status Of Children With Cystic Fibrosis X-Sectional Study nanCOMPLETED
Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD) nanCOMPLETED
Genetic and Epidemiologic Studies of Premature Coronary Artery Disease - SCOR in Arteriosclerosis nanCOMPLETED
Markers in Acute Pancreatitis-1 nanCOMPLETED
Surfactant Derived Protocol in Heart Failure nanCOMPLETED
Blood Test for Early Detection of Breast Cancer Using Todos Medical -Breast 1(TM-B1) Assay nanUNKNOWN
Trans Fatty Acids and Cardiovascular Risk Factors nanCOMPLETED
Pancreatic Exocrine Insufficiency and Pancreatic Enzyme Supplementation in Critically Ill Adult Patients nanCOMPLETED
Presepsin as a Predictor for Postoperative Complications Following Pancreatic Resection nanCOMPLETED
Triglyceride-rich LIPoproteins and INflammatory Cytokines After Oral FAT Loading as Potential Early Biomarkers of the Risk of Progression Towards DIABETES and Development of Complications. LIPINFAT Diabetes Study. nanRECRUITING
Influence of Genetic Polymorphisms on Ventricular Structure and Function in Patients With Single Ventricle Anatomy nanCOMPLETED
CTRP3 and Progranulin in Patients With Coronary Artery Disease nanCOMPLETED
Post Acute Pancreatitis Pancreatic Exocrine Insufficiency nanCOMPLETED
Gastrointestinal Study at Orkambi Therapy in CF Patients nanUNKNOWN
Defining the Molecular and Physiological Mechanisms of Pancreatic Islet Cell Dysfunction Which Lead to Type 2 Diabetes nanCOMPLETED
Identifying Maturity-onset Diabetes of the Young in Emirati Patients nanNOT_YET_RECRUITING
Exocrine Pancreatic Function Testing in Cystic Fibrosis nanUNKNOWN
Genetics of the Metabolic Syndrome in Japanese Americans nanCOMPLETED
Genetic Modifiers of Cystic Fibrosis: Sibling Study nanCOMPLETED
Plasma Triglyceride Lipolysis in Multifactorial Chylomicronemia nanCOMPLETED
Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3 nanCOMPLETED
SR-BI and Antiviral Treatment Response in HCV nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a CTRB1 binder may also engage these)

ProteinNameSimilarity
P04813 1.000 P04813 →
CTRB2 Chymotrypsinogen B2 (EC 3.4.21.1) [Cleaved in 1.000 landscape →
P07338 0.999 P07338 →
Q9CR35 0.997 Q9CR35 →
P80646 0.996 P80646 →
P00767 0.993 P00767 →
P00766 0.991 P00766 →
P47796 0.988 P47796 →
P51588 0.984 P51588 →
P29787 0.984 P29787 →
P00755 0.982 P00755 →
P00759 0.981 P00759 →
P00756 0.981 P00756 →
P80009 0.980 P80009 →
P29786 0.979 P29786 →
Q924N9 0.978 Q924N9 →
Q27289 0.978 Q27289 →
P35037 0.978 P35037 →
P15949 0.978 P15949 →
Q17025 0.978 Q17025 →
P15947 0.977 P15947 →
P07647 0.977 P07647 →
C6ZDB5 0.977 C6ZDB5 →
Q61754 0.977 Q61754 →
Q07943 0.977 Q07943 →
P32824 0.976 P32824 →
P80010 0.976 P80010 →
P81286 0.976 P81286 →
P15945 0.976 P15945 →
Q91508 0.976 Q91508 →